HBT Stock Analysis: Hbt Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.363m USD | 12M Return: 59.4% | US4041111067 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.20M
EPS Trend: 34.9%
Qual. Beats: 0
Rev. Trend: 89.8%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 7.1 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
HBT Financial, Inc. is the bank holding company for Heartland Bank and Trust Company, providing a full suite of banking, lending, and wealth management services to consumers, businesses, and municipal entities across Illinois and Eastern Iowa. Founded in 1920 and headquartered in Bloomington, Illinois, the company was formerly known as Heartland Bancorp, Inc. before adopting its current name in September 2019, ahead of its October 2019 IPO.
The companys deposit offerings include checking, money market, savings, certificates of deposit, HSA, and IRA accounts, while its lending portfolio spans commercial real estate, construction and land development, multi-family, commercial and industrial, agricultural, residential, and municipal loans. HBT also provides digital banking, treasury management, trust and investment services, retail brokerage, retirement plan administration, and farm management services including crop insurance and farmland brokerage.
As a community-oriented regional bank, HBT operates in two states with a notable concentration in agricultural and farmland lending, which aligns with the dominant farming economy of central Illinois and Eastern Iowa. Its diversified mix of traditional banking, wealth management, and specialty services such as farm management reflects the relationship-based business model typical of smaller-cap U.S. regional banks serving local markets.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan losses pressure earnings
- Agricultural lending demand softens with farm income decline
| Net Income: 89.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.02 > 1.0 |
| NWC/Revenue: -1.13k% < 20% (prev -1.26k%; Δ 124.2% < -1%) |
| CFO/TA 0.02 > 3% & CFO 104.2m > Net Income 89.4m |
| Net Debt (-1.47b) to EBITDA (129.7m): -11.33 < 3 |
| Current Ratio: 0.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.5m) vs 12m ago 15.91% < -2% |
| Gross Margin: 80.92% > 18% (prev 79.22%; Δ 1.71% > 0.5%) |
| Asset Turnover: 6.17% > 50% (prev 5.82%; Δ 0.35% > 0%) |
| Interest Coverage Ratio: 1.75 > 6 (EBIT TTM 121.2m / Interest Expense TTM 69.2m) |
| A: -0.61 (Total Current Assets 1.66b - Total Current Liabilities 5.76b) / Total Assets 6.72b |
| B: 0.06 (Retained Earnings 412.8m / Total Assets 6.72b) |
| C: 0.02 (EBIT TTM 121.2m / Avg Total Assets 5.88b) |
| D: 0.13 (Book Value of Equity 754.1m / Total Liabilities 5.97b) |
| Altman-Z'' = -3.53 = D |
| DSRI: 1.35 (Receivables 39.4m/23.6m, Revenue 362.3m/292.8m) |
| GMI: 0.98 (GM 79.22% / 80.92%) |
| AQI: 0.87 (AQ_t 0.74 / AQ_t-1 0.85) |
| SGI: 1.24 (Revenue 362.3m / 292.8m) |
| TATA: -0.00 (NI 89.4m - CFO 104.2m) / TA 6.72b) |
| Beneish M = -2.67 (Cap -4..+1) = A |
As of November 20, 2026, the stock is trading at USD 35.52 with a total of 138,624 shares traded. Over the past week, the price has changed by -5.25%, over one month by +1.57%, over three months by +0.96% and over the past year by +59.41%.
Current recommended Stop Loss: 34.40 (which is 3.2% or 1.3 ATR below the current price).
Hbt Financial has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold HBT.
- StrongBuy: 1
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42 | 18.2% |
P/E Trailing = 14.4749
P/S = 4.6786
P/B = 1.7983
Revenue TTM = 362.3m USD
EBIT TTM = 121.2m USD
EBITDA TTM = 129.7m USD
Long Term Debt = 149.2m USD (from longTermDebt, last quarter)
Short Term Debt = 12.2m USD (from shortTermDebt, last quarter)
Debt = 149.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.47b USD (calculated: Debt 149.2m - CCE 1.62b)
Enterprise Value = 1.36b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.75 (Ebit TTM 121.2m / Interest Expense TTM 69.2m)
EV/FCF = 14.51x (Enterprise Value 1.36b / FCF TTM 94.0m)
FCF Yield = 6.89% (FCF TTM 94.0m / Enterprise Value 1.36b)
FCF Margin = 25.94% (FCF TTM 94.0m / Revenue TTM 362.3m)
Net Margin = 24.67% (Net Income TTM 89.4m / Revenue TTM 362.3m)
Gross Margin = 80.92% ((Revenue TTM 362.3m - Cost of Revenue TTM 69.1m) / Revenue TTM)
Gross Margin QoQ = 81.14% (prev 79.88%)
Tobins Q-Ratio = 0.20 (Enterprise Value 1.36b / Total Assets 6.72b)
Interest Expense / Debt = 46.35% (Interest Expense 69.2m / Debt 149.2m)
Taxrate = 26.26% (31.8m / 121.2m)
NOPAT = 89.4m (EBIT 121.2m * (1 - 26.26%))
Current Ratio = 0.29 (Total Current Assets 1.66b / Total Current Liabilities 5.76b)
Debt / Equity = 0.20 (Debt 149.2m / totalStockholderEquity, last quarter 754.1m)
Debt / EBITDA = -11.33 (Net Debt -1.47b / EBITDA 129.7m)
Debt / FCF = -15.64 (Net Debt -1.47b / FCF TTM 94.0m)
Total Stockholder Equity = 720.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.52% (Net Income 89.4m / Total Assets 6.72b)
RoE = 12.41% (Net Income TTM 89.4m / Total Stockholder Equity 720.4m)
RoCE = 13.94% (EBIT 121.2m / Capital Employed (Equity 720.4m + L.T.Debt 149.2m))
RoIC = 9.42% (NOPAT 89.4m / Invested Capital 948.8m)
WACC = 8.83% (E(1.36b)/V(1.51b) * Re(6.06%) + D(149.2m)/V(1.51b) * Rd(46.35%) * (1-Tc(0.26)))
Discount Rate = 6.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 75.53 | Cagr: 6.50%
[DCF] Terminal Value 76.42% ; FCFF base≈84.9m ; Y1≈97.3m ; Y5≈143.2m
[DCF] Fair Price = 95.03 (EV 1.99b - Net Debt -1.47b = Equity 3.46b / Shares 36.4m; r=8.83% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 34.92 | EPS CAGR: 1.53% | SUE: 0.76 | # QB: 0
Revenue Correlation: 89.78 | Revenue CAGR: 9.07% | SUE: 1.19 | # QB: 2
EPS current Quarter (2027-03-31): EPS=0.82 | Chg30d=+3.54% | Revisions=+62% | Analysts=5
EPS current Year (2026-12-31): EPS=3.15 | Chg30d=+3.62% | Revisions=+62% | GrowthEPS=+24.9% | GrowthRev=+33.1%
EPS next Year (2027-12-31): EPS=3.57 | Chg30d=+3.36% | Revisions=+62% | GrowthEPS=+13.3% | GrowthRev=+25.0%
[Analyst] Revisions Ratio: +83% (up=15, down=0)